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INTRODUCTION 
 
Mutations of some genes cause severe defects in an 
organism’s health, while mutations of other genes cause 
subtle effects on health. Genes with modulatory effects 
may be involved in how well an organism can maintain 
its health and how long an organism can survive. One 
aspect of health that determines quality of life in the 
elderly is locomotor ability [1]. Age-related decline in 
locomotor ability is a predictor of loss of independence, 
depressive symptoms, morbidity, and mortality [2]. A 
better understanding of the factors that contribute to the 
maintenance of locomotor ability may enable novel 
approaches to prevent or delay age-related decline in 
locomotor ability and general health.  
 
The nematode Caenorhabditis elegans provides a 
unique opportunity to study locomotor healthspan due  
to the availability of genetic techniques and its short 
lifespan of approximately two weeks [3]. From a 
candidate-based screen of genes that extend the 
swimming ability of aged C. elegans worms, the 
epidermal growth factor signalling pathway was found 
to extend locomotor healthspan and lifespan [4]. 
Recently, loss-of-function mutations in the calcium-
activated potassium channel, SLO-1, were found to 
improve locomotor healthspan and lifespan in C. 
elegans [5].  
 
In Sydney Brenner’s seminal forward genetic screen 
using C. elegans, he isolated uncoordinated (unc) 
mutants and identified genes that are required for the 
proper development of locomotor ability [3]. In order to 
identify novel genetic factors that play modulatory roles 
in the maintenance of locomotor healthspan, we 
previously carried out an unbiased forward genetic 
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Some genes are essential for survival, while other genes play modulatory roles on health and survival. Genes that 
play modulatory roles may promote an organism’s survival and health by fine-tuning physiological processes. An 
unbiased search for genes that alter an organism’s ability to maintain aspects of health may uncover modulators of 
lifespan and healthspan. From an unbiased screen for Caenorhabditis elegans mutants that show a progressive 
decline in motility, we aimed to identify genes that play a modulatory role in maintenance of locomotor 
healthspan. Here we report the involvement of hda-3, encoding a class I histone deacetylase, as a genetic factor 
that contributes in the maintenance of general health and locomotion in C. elegans. We identified a missense 
mutation in HDA-3 as the causative mutation in one of the isolated strains that show a progressive decline in 
maximum velocity and travel distance. From transcriptome analysis, we found a cluster of genes on Chromosome II 
carrying BATH domains that were downregulated by hda-3. Furthermore, downregulation of individual bath genes 
leads to significant decline in motility. Our study identifies genetic factors that modulate the maintenance of 
locomotor healthspan and may reveal potential targets for delaying age-related locomotor decline. 
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screen and isolated five C. elegans mutants that show 
progressive decline in motility [6]. 
 
In the present study, we analyzed one of the isolated 
strains from the screen, OF1262, to identify genes that 
modulate the maintenance of locomotor healthspan. 
From analyzing this strain, we found that a missense 
mutation in HDA-3 leads to reduced health, including 
progressive decline in maximum velocity, travel 
distance, and reduced longevity. HDA-3 is a C. elegans 
ortholog of human class I histone deacetylases 
(HDACs) [7]. C. elegans class I HDACs have been 
found to play roles in both development and aging-
related pathologies. Loss of HDA-1 function leads to 
disorganized gonad structures and aberrant vulval 
development such as protruded vulva or the 
development of multiple vulvae [8, 9]. C. elegans class 
I HDACs have also been found to play a role in 
polyglutamine toxicity and longevity [10, 11]. The 
missense mutation identified in the OF1262 strain is a 
glycine to glutamic acid substitution at the 271st amino 
acid (G271E) in HDA-3. This mutation causes a gene 
cluster carrying BATH domains to be transcriptionally 
repressed. Proper regulation of gene expression by 
HDA-3 may be required for full maintenance of 




OF1262 strain that shows shortened adult locomotor 
healthspan carries hda-3(ix241) and dys-1(ix259) 
mutations  
 
Previously, we carried out a forward genetic screen for 
C. elegans mutants with a shortened adult locomotor 
healthspan [6]. One of the isolated strains was the 
OF1262 strain which showed a slight developmental 
deficit and a marked progressive decline in the ability to 
reach a food source located on the outer edge of an agar 
plate (Figure 1A, 1B) [6]. The OF1262 strain shows a 
progressive decline in maximum velocity and travel 
distance during adulthood as measured by 1.0-minute 
video recordings of worms moving on an agar plate 
without food. OF1262 worms show a progressive 
decline in maximum velocity and travel distance even 
when measured on a plate without a food cue, 
suggesting the decline is likely not due to defects in the 
sensory system. Maximum velocity is the highest 
velocity that the worm reaches during the 1.0-minute 
video recording, while travel distance is the total 
distance that the worm covers. Together, these measures 
estimate the maximum neuromuscular capacity of 
worms, as well as the capacity to maintain a certain 
level of locomotion. In all of the strains we tested, we 
observed similar trends between maximum velocity and 
travel distance, and thus display only the maximum 
velocity measurements in the main figures and show the 
travel distance measurements in the supplementary 
figures. We observed variations in both measurements 
among separate experiments, suggesting sensitivity of 
the assay to slight differences in culture conditions such 
as temperature and humidity. 
 
In order to identify the causative mutation site that leads 
to progressive decline in maximum velocity and travel 
distance in the OF1262 strain, we carried out whole 
genome sequencing in strains that showed and did not 
show the progressive decline after backcrossing. We 
identified mutations that were shared among the 
genomes of backcrossed strains that showed the 
progressive decline in maximum velocity, and 
subtracted the shared mutations among backcrossed 
strains that did not show the progressive decline in 
maximum velocity. A peak of mutations remained on 
Chromosome I (Figure 1C, 1D, Supplementary  
Table 1).  
 
Two notable mutations remained after four backcrosses 
on Chromosome I: hda-3(ix241) and dys-1(ix259). hda-
3(ix241) is a mutation in hda-3 that leads to a glycine to 
glutamic acid substitution at the 271st amino acid 
(G271E) (Figure 1E). dys-1(ix259) is a splice site 
mutation in dys-1 (Figure 1F). hda-3 and dys-1 are 
located in close proximity on Chromosome I. OF1263, a 
strain which was backcrossed four times to the wild-
type (WT) strain, and other backcrossed strains retained 
an exaggerated head bending phenotype. Exaggerated 
head bending has previously been observed in mutants 
with loss-of-function mutations to dys-1, the C. elegans 
ortholog of human Dystrophin (Figure 1G), and to 
genes encoding components of the Dystrophin 
associated protein complex (DAPC) [12–17]. We 
postulated that the exaggerated head-bending and the 
progressive decline in maximum velocity are linked and 
caused by the same underlying mutation. However, 
after the fifth backcross, we isolated OF1350, a strain 
that carried the dys-1(ix259) mutation and showed 
exaggerated head-bending, but did not show the 
progressive decline in maximum velocity and travel 
distance (Figure 1H, 1I; Supplementary Figure 1A, 1B). 
This result suggested that the dys-1(ix259) mutation is 
not sufficient to cause the locomotor deficit. This came 
as a surprise since Dystrophin, the human ortholog of 
DYS-1 is implicated in progressive muscle weakness 
[17, 18].  
 
hda-3 mutation causes progressive decline in 
maximum velocity and travel distance  
 
The effect of the hda-3(ix241) mutation was tested by 
two strategies. In the first strategy, CRISPR-Cas9 
genome editing was used to revert the hda-3(ix241) 
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Figure 1. OF1262 strain shows locomotor deficit and carries hda-3(ix241) and dys-1(ix259) mutations. (A) Schematic of forward 
genetic screen to isolate OF1262 strain, a strain that shows progressive decline in adult motility. (B) Percent change in completion rate of the 
Edge Assay on adult day 5 compared to adult day 1. N = 3 biological replicate plates (100 worms or more per plate on adult day 1). (C) 
Mutation frequency along each chromosome for the OF1262 strain. Red bars indicate 0.5-Mb bins and grey bars indicate 1.0-Mb bins. (D) 
Mutation frequency along each chromosome for remaining mutations after subtracting mutations found in backcrossed strains that did not 
show a progressive decline in locomotor ability from mutations found in backcrossed strains that showed a progressive decline in locomotor 
ability. (E) Effect of hda-3(ix241) mutation on DNA sequence and amino acid sequence. (F) Effect of dys-1(ix259) mutation on DNA sequence. 
(G) Photos of head curvature during forward crawling in WT, dys-1(cx18) and dys-1(eg33) worms. Exaggerated head bending indicated by 
arrows. (H) (Top) Photo of head curvature during forward crawling in OF1350 dys-1(ix259) worms. (Bottom) DNA sequence of dys-1(ix259) 
mutation site. (I) (Left) Maximum velocities of WT, OF1263 hda-3(ix241);dys-1(ix259) (4x BC), and OF1350 dys-1(ix259) (5x BC) worms. N = 
30–45 worms per strain for each day (10–15 worms from 3 biological replicate plates). (Right) Percent change in maximum velocity of WT, 
OF1263, and OF1350 worms on adult day 5 compared to adult day 1. N = 3 biological replicate plates. ***p < 0.001; **p < 0.01.   
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mutation in the OF1263 hda-3(ix241);dys-1(ix259) 
strain (Figure 2A). In order to prevent repetitive editing, 
a synonymous mutation was introduced that would 
disrupt the protospacer adjacent motif (PAM) sequence, 
5 bp upstream of the editing site (Figure 2A). We refer 
to this reverted allele as hda-3(ix260), which has the 
same HDA-3 amino acid sequence as WT HDA-3. In 
the second strategy, the HDA-3 G271E mutation was 
introduced into the WT N2 background using CRISPR-
Cas9 genome editing. Again, a synonymous mutation 
was introduced that would disrupt the PAM sequence 
(Figure 2A). We refer to this mutation allele as hda-
3(ix261), which causes the same HDA-3 G271E 
mutation as the hda-3(ix241) mutation in the WT 
background. Strains carrying hda-3(ix261) were 
backcrossed twice. 
The reversion of the hda-3(ix241) mutation to hda-
3(ix260) rescued the progressive decline in maximum 
velocity and travel distance (Figure 2B, Supplementary 
Figure 2A). This result indicated that the hda-3(ix241) 
mutation is necessary for the progressive decline in 
maximum velocity and travel distance. In the hda-
3(ix261) strain that carries the G271E mutation in the 
N2 WT background, progressive decline in maximum 
velocity and travel distance was observed (Figure 2C, 
Supplementary Figure 2B). This result indicated that the 
HDA-3 G271E mutation alone is sufficient to cause 
progressive decline in maximum velocity and travel 
distance. In addition, an independently isolated hda-
3(ok1991) deletion strain showed progressive decline in 
maximum velocity and travel distance (Figure 2D, 




Figure 2. HDA-3 G271E missense mutation leads to progressive decline in locomotor ability. (A) (Left) Sequence of hda-3(ix260) 
allele which is the same amino acid sequence as WT. (Right) Sequence of hda-3(ix261) allele which is the same amino acid sequence as the 
hda-3(ix241) allele. Both sequences carry a synonymous mutation site to disrupt the PAM sequence to prevent repetitive editing by CRISPR-
Cas9. (B) (Left) Maximum velocities of WT, OF1263 hda-3(ix241);dys-1(ix259) (4x BC), OF1353 hda-3(ix260);dys-1(ix259) and OF1354 hda-
3(ix260);dys-1(ix259) worms. (Right) Percent change in maximum velocity of WT, OF1263, OF1353 and OF1354 worms on adult day 5 
compared to adult day 1. (C) (Left) Maximum velocities of WT, OF1355 hda-3(ix261), OF1356 hda-3(ix261) worms. (Right) Percent change in 
maximum velocity of WT, OF1355 hda-3(ix261), OF1356 hda-3(ix261) worms on adult day 5 compared to adult day 1. (D) (Left) Maximum 
velocities of WT and hda-3(ok1991) worms. (Right) Percent change in maximum velocity of WT and hda-3(ok1991) worms on adult day 5 
compared to adult day 1. For maximum velocity measurements, N = 30–45 worms per strain for each day (10–15 worms from 3 biological 
replicate plates). For percent change in maximum velocity graphs, N = 3 biological replicate plates. ***p < 0.001; **p < 0.01; *p < 0.05. 
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hda-3(ix241) mutation did not however reverse the 
minor locomotor deficit observed on the first day of 
adulthood (Figure 2B). Given that OF1350 dys-1(ix259) 
did not show a locomotor deficit on the first day of 
adulthood (Figure 1I), there may be other mutations in 
the background of OF1353 and OF1354 that lead to 
minor deficits on the first day of adulthood. Another 
possibility is that the synonymous codon mutation we 
introduced in the PAM site (CGG>CGA) for CRISPR 
genome editing may have unanticipated effects on the 
locomotor ability of worms.  
 
The G271 residue is evolutionarily conserved from C. 
elegans to humans and is located in the variable loop 
region (Figure 3A, 3B; Supplementary Figure 3A). The 
variable loop region is suggested to play a role in 
substrate recognition and binding to the HDAC 
cofactors zinc and inositol phosphate [19, 20] (Figure 
3B). The C. elegans G271 amino acid aligns with 
human HDAC3 G267. The HDAC3 G267 amino acid is 
in close proximity to R265, which is an amino acid that 
mediates the interaction between HDAC3 and its 
coactivator, inositol phosphate [19, 21]. HDAC3 D259 
is also in close proximity which is predicted to mediate 
the interaction between HDAC family proteins with the 
cofactor zinc [20]. The G271E mutation may alter 
activities of HDA-3 that play a role in the maintenance 
of locomotor ability. 
 
Longevity is reduced in hda-3 mutants 
 
Since HDA-3 has previously been reported to be 
expressed ubiquitously [10], we tested whether 
mutation in HDA-3 may have effects on general 
aspects of health and longevity. The median lifespans 
of hda-3(ix261) mutants were reduced from 16 days to 
15 days compared to WT worms (Figure 4A). The 
hda-3(ix261) mutants shared a comparable reduction 
in lifespan as hda-3(ok1991) mutant worms that carry 
a deletion in hda-3. The body length of the strain 
OF1355 hda-3(ix261) was unchanged compared to 
that of WT worms, but another strain, OF1356 hda-
3(ix261) (Figure 4B), was shorter and may carry 
additional mutations besides hda-3(ix261) that have 
minor effects on body size. There were no significant 
differences in the development times and brood sizes 
of the hda-3(ix261) mutant worms and WT (Figure 
4C, 4D).   
 
OF1355 and OF1356 worms showed a 25 % reduction 
in survival 1 day earlier than WT worms (Figure 4A), 
while they showed a 25 % decline in maximum 
velocity 3 days earlier than WT worms (Figure 2C). 
This suggests that the negative effects of the hda-
3(ix261) mutation affect maximum velocity more 
strongly than lifespan. 
Expression of subset of BATH genes are 
dysregulated in hda-3 mutant strains 
 
In order to identify gene expression changes that occur 




Figure 3. HDA-3 G271E missense mutation occurs at 
evolutionarily conserved residue. (A) (Top) Depiction of hda-
3(ix241) mutation site in HDA-3 protein. (Bottom) Alignment of 
amino acid sequences centered around G271E mutation site in C. 
elegans HDA-3, H. sapiens HDAC1, HDAC2 and HDAC3. (B) (Top) 
Structural modeling of C. elegans WT HDA-3 based on PDB: 4A69 
from H. Sapiens HDAC3. (Bottom) Structural modeling of C. 
elegans HDA-3 G271E based on PDB: 4A69 from H. Sapiens 
HDAC3. Mutated glutamic acid residue is shown in magenta. 
HDAC domain is indicated in blue. 
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analysis was carried out in adult worms on the third day 
of adulthood. On the third day of adulthood, WT worms 
did not show decline in maximum velocity and travel 
distance whereas hda-3(ix241) worms showed 
significant declines compared to the first day of 
adulthood (Figure 1I). Therefore, we reasoned that 
genes that play a role in the maintenance of adult 
maximum velocity and travel distance may be 
differentially expressed between WT and hda-3(ix241) 
worms on the third day of adulthood.  
 
In comparison to WT worms, OF1263 hda-
3(ix241);dys-1(ix259) worms had 64 transcripts that 
were significantly upregulated and 47 transcripts that 
were significantly downregulated (FDR-adjusted q 
value < 0.05) (Figure 5A). In comparison to OF1350 
dys-1(ix259) worms, which lost the hda-3(ix241) 
mutation after the fifth backcross, OF1263 worms had 
27 transcripts that were significantly upregulated and 25 
transcripts that were significantly downregulated 
(Figure 5A). Twenty-two transcripts were commonly 
upregulated in the OF1263 worms compared to WT and 
OF1350. Thirteen transcripts were commonly 
downregulated in the OF1263 worms compared to WT 
and OF1350 (Figure 5B).  
 
Among the downregulated transcripts, we noticed that 
multiple gene transcripts were downregulated within 
two narrow regions of the genome on Chromosome II 
and Chromosome IV (Figure 6A; Supplementary Figure 
4A). On Chromosome II, the downregulated genes are 
bath-1, bath-21, and bath-24 which carry BATH 
domains (Figure 6A, 6B) [22, 23]. BATH domains are 
characterized by BTB/POZ (broad-complex, Tramtrack 
and bric-a-bric/Pox virus and zinc finger) and MATH 
(meprin-associated Traf homology) domains [23]. 
Downregulation of bath-1, bath-21 and bath-24 were 
observed in both hda-3(ix261) mutant worms and hda-
3(ok1991) mutant worms (Figure 6C, 6D). HDA-3 







Figure 4. HDA-3 mutation leads to shortened lifespan. (A) Lifespan of WT (N = 80), OF1355 hda-3(ix261) (N=60), OF1356 hda-3(ix261) 
(N=66), and hda-3(ok1991) worms (N = 64). (B) Body length of WT, OF1355 hda-3(ix261), and OF1356 hda-3(ix261) worms. N = 10-17 worms 
per strain. (C) Development time of WT, OF1355 hda-3(ix261), and OF1356 hda-3(ix261) worms. N = 8-10 worms per strain. (D) Brood size of 
WT, OF1355 hda-3(ix261), and OF1356 hda-3(ix261) worms N = 5-6 worms per strain. *p < 0.05.  
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of the chromosome region which encompasses bath-1, 
bath-21, and bath-24. In addition, a less stringent 
threshold for downregulation of genes (unadjusted p 
value < 0.05) indicates that bath-3, bath-5, and btb-4 are 
also downregulated in the OF1263 strain 
(Supplementary Table 2). btb-4 carries the BTB-
domain, one of the two domains that characterize 
BATH genes. INTERPRO protein domain enrichment 
analysis of the differentially expressed genes (p < 0.05) 
indicates that BTB and MATH domains are most 
significantly enriched among downregulated genes 
(Supplementary Table 3). Interestingly, histone genes 
(his-73, his-47, his-61, his-25, his-63, his-60) that are 
constituents of the nucleosome are also a category of 
genes that are overrepresented among downregulated 
genes, but not in the upregulated genes (Supplementary 
Table 3). Precise regulation of the composition of 
histone variants may be carried out by HDA-3. 
In order to test whether bath genes alone could have 
effects on motility, we knocked down bath-1, bath-21, 
and bath-24 separately using feeding RNAi, and 
measured maximum velocity and travel distance. bath-
1, bath-21, and bath-24 individually had subtle but 
significant effects on maximum velocity and travel 
distance starting at the fifth day of adulthood (Figure 
6E; Supplementary Figure 5A). These results suggest 
that bath genes may normally act to promote locomotor 





The role of class I HDACs during the aging process has 
been difficult to study, as HDAC1, HDAC2, HDAC3, 
and HDAC8 have been found to play important roles 




Figure 5. Gene expression is dysregulated in hda-3 mutant. (A) (Left) Volcano plot of differential expression of transcripts from 
OF1263 hda-3(ix241);dys-1(ix259) (4x BC) vs. WT worms. (Right) Volcano plot of differential expression of transcripts from OF1263 hda-
3(ix241);dys-1(ix259) (4x BC) vs. OF1350 dys-1(ix259) (5x BC) worms. Blue points indicate downregulated genes and red points indicate 
upregulated genes with q value < 0.05 (FDR-adjusted p value). (B) (Left) Venn diagram of number of significantly upregulated transcripts with 
q < 0.05 in OF1263 vs. WT worms and OF1263 vs. OF1350 worms. (Right) Venn diagram of number of significantly upregulated and 
downregulated transcripts with P < 0.0001 in OF1263 vs. WT and OF1263 vs. OF1350 worms. Names of commonly upregulated or 
downregulated genes are indicated within the Venn diagram. 
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HDAC3 knockout mice die during embryonic 
development [25]. HDACs have been linked to playing 
a role during the aging process as HDAC inhibitors 
have been shown to promote longevity in C. elegans 
and D. melanogaster [26–28]. HDAC inhibitors are also 
proposed to be therapeutic targets for various age-
related pathologies such as sarcopenia and 




Figure 6. Specific BATH genes on Chromosome II are downregulated from HDA-3 mutations. (A) Genomic location of strongly 
downregulated gene transcripts on Chromosome II in OF1263 vs. WT. (B) Locations of BATH genes on Chromosome II. (C) Fold change in 
BATH genes in OF1355 hda-3(ix261) worms compared to WT, as measured by qPCR. (D) Fold change in BATH genes in hda-3(ok1991) worms 
compared to WT, as measured by qPCR. (E) Maximum velocities of worms fed with empty vector RNAi or RNAi targeted towards bath-1, 
bath-21, or bath-24. N = 30–45 worms per strain for each day (10–15 worms from 3 biological replicate plates). ***p < 0.001; **p < 0.01; *p < 
0.05. 
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Histone deacetylases can affect the transcriptional 
expression of many downstream genes [32]. Generally, 
histone acetylation is positively associated with 
transcriptional activation and deacetylation is associated 
with transcriptional repression [33]. However, other 
studies have found that HDACs are involved in both 
repression and activation [34, 35]. Our results show that 
hda-3(ix241) and hda-3(ok1991) mutations can lead to 
reduced expression of a subset of genes, and suggest 
that HDA-3 normally acts to promote expression of 
some genes. It is also possible that histone deacetylases 
may affect transcriptional outputs by mechanisms other 
than histone acetylation. HDAC3 can directly interact 
with transcription factors GATA-2 and Runx2 to 
repress their transcriptional activity [36, 37]. Histone 
deacetylases may affect transcriptional outputs by direct 
interactions or modifications to non-histone proteins.  
 
Transcriptome analysis and quantitative PCR analyses 
of mutant strains carrying the HDA-3 G271E mutation 
indicated a region in the genome that is transcriptionally 
repressed on Chromosome II. The Chromosome II 
region carried genes of related function, bath-1, bath-3, 
bath-5, bath-21, bath-24, and btb-4 that contain 
BTB/POZ and/or MATH domains [23]. Genes that 
contain both BTB and MATH domains are referred to 
as bath genes [23]. bath genes are reported to be 
involved in proteasomal degradation by association with 
CULLIN3 (CUL3), an E3 ubiquitin ligase [38, 39]. The 
BTB domain is reported to bind CUL3, while the 
MATH domain binds specific substrates to be degraded 
[38, 40]. Based on our study, bath genes may be part of 
the subset of genes that work to maintain locomotor 
healthspan during later stages of reproductive 
adulthood. 
 
BATH-42 has been implicated in the regulation of 
nicotinic acetylcholine receptors by interacting with 
the CUL-3 ubiquitin ligase complex in C. elegans 
[41]. Expression of genes carrying BATH domains 
may be important for regulating the expression levels 
of other proteins that play a role in maintaining adult 
locomotor ability. As part of the ubiquitin-proteasome 
system, CUL-3 and BATH-domain carrying proteins 
may promote proteostasis by targeting misfolded 
proteins for degradation. bath-24 was found to be 
enriched in unc-4::GFP expressing motor neurons, 
pointing towards a possible role in motor neuron 
functioning and locomotion [42]. bath-1 and bath-21 
are reported to be enriched in germline, suggesting 
possible indirect roles in regulating healthspan [43]. 
Although the specific mechanism in which hda-3 and 
bath genes regulate locomotor healthspan is yet to be 
determined, they may do so by direct and indirect 
mechanisms originating from the neuromuscular 
system or other tissues.  
The HDA-3(G271E) mutation occurs at an 
evolutionarily conserved residue. The same residue is 
present in human HDACs 1–3. The C. elegans G271 
amino acid aligns with human HDAC3 G267. From 
exome and whole genome sequencing of the non-
diseased human population, no missense mutations 
were reported in the HDAC3 G267 residue [44]. The 
G267 residue in human HDAC3 may be intolerant to 
amino acid changes, and thus play a critical role in 
proper HDAC3 function. The HDAC3 G267 amino acid 
is located in Variable Loop 4, one of the four variable 
loop regions which is implicated in substrate 
recognition [45]. The variable loops are different in 
length and sequence among the different HDAC 
proteins, enabling the recognition of specific substrates 
for each HDAC protein. Interestingly, all HDAC 
proteins, except for HDAC8, carry a glycine residue at 
the amino acid location aligned to HDAC3 G267. 
HDAC8 carries a cysteine residue instead of glycine. 
HDAC8 is believed to be evolutionarily divergent from 
the other class I histone deacetylases HDAC1-3 [46]. 
HDAC8 may have tissue-specific roles that are 
mediated by unique differences in amino acid sequence 
from the other HDAC proteins [47].  
 
Since C. elegans can tolerate the loss of hda-3 during 
development, the HDA-3 G271E mutants and hda-
3(ok1991) deletion mutant may be valuable tools to 
study the role of a specific class I histone deacetylase 
during aging. Unbiased genomic screens have found 
that knockdown of hda-3 leads to increased genome 
instability and plays a role in RNAi-mediated gene 
silencing [48]. The HDA-3 G271E mutants and hda-
3(ok1991) deletion mutant have a reduced lifespan, and 
therefore may be used to identify genetic regulators of 
longevity downstream of HDA-3. Interestingly, 
Edwards et al. found that RNAi knockdown of hda-3 
leads to a 16% increase in lifespan for C. elegans [11]. 
Although the culture method in which C. elegans 
lifespan was measured differed between our study (agar 
plates) and Edwards et al. (liquid culture), partial 
reductions in HDA-3 function may have positive 
downstream gene expression changes for lifespan, while 
loss-of-function mutations to HDA-3 may have negative 
gene expression changes.  
 
Genetic screens in C. elegans have identified various 
genes involved in locomotion. Upregulation of the EGF 
signaling pathway or downregulation of SLO-1 function 
have been shown to improve locomotion during 
adulthood [4, 5]. In a previous study, we identified a 
nonsense mutation in elpc-2 that leads to progressive 
decline in maximum velocity and travel distance [6]. 
The role of elpc-2 as part of the Elongator complex 
implicates the role of tRNA modifications for the 
maintenance of proteostasis and adult locomotor ability. 
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In this study, we identify the G271E mutation in HDA-3 
as the causative mutation site that leads to progressive 
decline in maximum velocity and travel distance. HDA-
3 alters the transcription of BATH-domain genes 
located in close proximity on Chromosome II. In 
concert with the E3 ubiquitin ligase CUL-3, BATH-
domain proteins may also regulate specific expression 
of proteins involved in motility, or affect proteostasis in 
a broader context. Together, these mutants provide 
insights into the genetic mechanisms that contribute to 
the maintenance of adult locomotor ability and may aid 
our understanding of the genetic bases of healthy aging. 
 




C. elegans Bristol N2 strain was used as the WT strain. 
Worms were cultivated at 20° C on Nematode Growth 
Media (NGM) agar plates with Escherichia coli strain 
OP50 as a food source [3]. All strains used in this study 
are listed in Supplementary Table 4. 
 
Edge assay and mutant isolation 
 
The Edge Assay was performed as previously described 
[6]. In brief, Edge Assay plates were prepared by 
spreading 100 µL E. coli OP50 suspension near the edge 
of a circular 9 cm plate. “Synchronized egg-laying” was 
used to raise a batch of worms of similar age. 
Synchronized worms were collected with M9 buffer, and 
placed on the center of the Edge Assay plate. The Edge 
Assay completion rate was measured by counting the 
number of worms that reached the E. coli lawn near the 
edge of the plate divided by the total number of worms 
on the plate. The forward genetic screen to isolate 
worms with progressive decline in locomotor ability was 
performed using the Edge Assay as previously described 
[6]. In brief, L4 worms were mutagenized in 50 mM 
EMS solution for 4 h. Mutagenized F2 worms were 
placed on the center of Edge Assay plates on adult day 1. 
Worms that did not reach the edge within 15 minutes 
were removed by aspiration. Worms that reached the 
edge were maintained on the Edge Assay plate and 
tested again on adult day 3 and 5. The OF1262 strain 
was isolated as a worm that did not reach the edge on 
adult day 5. Isolated mutants that did not reach the edge 
were singled out on individual plates and maintained. 
Most worms produced at least a few progeny on adult 
day 5, but worms that did not produce progeny were 




Target genomic regions were amplified using PCR and 
purified using Wizard SV Gel and PCR Clean-Up 
System (Promega, Madison, WI). The DNA sequence 
of the PCR fragment was determined using cycle 
sequencing with BigDye v3.1 reagents (Applied 
Biosystems, Foster City, CA). Sequencing products 
were purified by EtOH/EDTA precipitation. 5 µL of 
125 mM EDTA was added and mixed thoroughly to the 
20 µL sequencing reaction. 60 µL of 100% ethanol was 
added and incubated for 15 min. The solution was 
centrifuged at 3000 x g for 30 min and the supernatant 
was discarded. 60 µL of 70% ethanol was added to the 
pellet and centrifuged at 1650 x g for 15 min. The 
supernatant was discarded, and the pellet was 
resuspended in 10 µL of Hi-Di Formamide (Applied 
Biosystems). Sequencing was performed by capillary 
sequencing using ABI3100 (Applied Biosystems). 
Primers used for Sanger sequencing are listed in 
Supplementary Table 5.  
 
Whole-genome DNA sequencing 
 
C. elegans DNA was extracted by ethanol 
precipitation. Mixed-stage worms were collected using 
M9 buffer, and washed 3 times with lysis buffer (200 
mM NaCl, 100 mM Tris-Hcl (pH 8.5), 50 mM EDTA, 
0.5% SDS). 10 µL of 10 mg/mL proteinase K was 
added to the 500 µL lysis buffer solution containing 
the worms. The solution was incubated at 55° C for at 
least 3 h. Proteinase K was deactivated by incubation 
at 95° C for 30 min. 20 µL of 20 mg/mL RNAase A 
was added and incubated at 37° C for 30 min. 125 µL 
of saturated NaCl was added, and the solution was 
centrifuged for 15 min at 15,000 rpm. 500 µL of the 
supernatant was transferred to a new tube containing 1 
mL of 100% ethanol. The solution was centrifuged at 
15,000 rpm for 20 min. The supernatant was discarded 
and 1 mL of 70% ethanol was added to the pellet. The 
solution was centrifuged at 15,000 rpm for 20 min. 
The supernatant was discarded and the pellet 
containing DNA was reconstituted in 100 µL TE 
buffer. DNA was sequenced using the MiSeq next-
generation sequencing system (Illumina, San Diego, 
CA) as previously described [6]. Libraries for 
sequencing were prepared with Illumina TruSeq 
Library Prep Kit. Sequenced reads were mapped using 
BWA software [49]. Mapped read files were converted 
to bam format, then to pileup format with Samtools 
[50]. Variant detection was carried out using VarScan 
and SnpEff [51–55]. Mutation effects were classified 
into four categories, (high, moderate, low, modifier) 
by SnpEff. The categorization of specific types of 
mutations are listed in the figure legend of 
Supplemetary Table 1. Mutations categorized as a high 
impact mutation were prioritized as most promising 
candidates that lead to the progressive decline in 
locomotion. Mutation frequencies were calculated and 
visualized using CloudMap [56].  
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Measurements of maximum velocity and travel 
distance  
 
Five adult day 1 worms were placed onto an NGM plate 
with food, and allowed to lay eggs for 3 h. When the 
offspring reached adult day 1, 15 worms were randomly 
picked onto a 6 cm NGM plate without bacteria. After 
the worms moved away from the initial location with 
residual food, worms were again moved onto a different 
NGM plate without bacteria. The maximum velocity 
and travel distance of worms were measured on the 
first, third, and fifth days of adulthood as previously 
described by video recording [6]. Videos were analyzed 
using ImageJ and wrMTrck software (www.phage. 
dk/plugins) to produce travel distance and maximum 
velocity values [57]. The same plate of worms 
measured on the first day of adulthood were measured 
on the third and fifth days of adulthood. For the percent 
change in maximum velocity or travel distance, the 
percentage decline from the first to fifth day of 
adulthood for each plate was calculated. Maximum 
velocity refers to the peak velocity that a worm reached 
during the 1.0 minute video recording. Travel distance 
refers to the total distance that the worm traveled during 
the 1.0-minute video recording. R was used to make 
plots [58].  
 
CRISPR-Cas9 genome editing 
 
Targeted mutagenesis was carried out using CRISPR-
Cas9 genome editing with single-stranded 
oligodeoxynucleotide (ssODN) donors as previously 
described [59]. First, a ribonucleoprotein complex was 
created by mixing together 0.5 µL of 10 µg/µL Cas9 
protein, 5.0 µL of 0.4 µg/µL of tracrRNA, and 2.8 µL 
of 0.4 µg/µL of crRNA (Target-specific sequence: 5’-
CCGAUUCACUGGCAGGAGAU-3’) and incubating 
at 37° C for 10 min. Following incubation, 2.2 µL of 1.0 
µg/µL ssODN, 2.0 µL of 400 ng/µL pRF4::rol-
6(su1006) co-injection marker, and 7.5 µL of nuclease 
free water was added to the mixture. This mixture was 
then injected into the gonad of young adult-stage worms 
subject to genomic editing. F1 offspring that showed the 
roller phenotype were singled onto individual plates, 
and allowed to lay eggs. Editing of the target sequence 
was checked by single worm PCR of the F1 worm, 
followed by Sanger sequencing. ssODN sequences are 




The lifespan of each worm strain was measured at  
20° C. Worms that did not respond to prodding to the 
head and tail were considered dead. Worms that died 
from an exploded vulva, bag-of-worms phenotype, or 
that were lost during the incubation period were 
censored.  Lifespan measurements were carried out in 
the absence of Floxuridine. 
 
Body length measurement 
 
Photos of age-synchronized worms were taken on the 
first day of adulthood. Worms were mounted on agar 
pads in M9 buffer containing 20 mM sodium azide. A 
central line through the entire body of the worm was 




Brood size was measured by allowing individual worms 
to lay eggs on a plate with food. The individual worm 
was moved to a fresh plate every 24 h until no more 
eggs were laid. The number of live larvae that were 
produced were counted on the next day. The total 
number of offspring that a single worm produced was 




The time from egg to first egg-lay was considered as the 
development time of the worm. Gravid adults were 
allowed to lay eggs within a 1-h time window. 
Individual eggs were picked and placed on individual 
plates with food. Beginning at 66 h of development, 
worms were checked each hour to see if they had laid 
any eggs. The first time point in which eggs were laid 




Worms were synchronized by placing ten adult day 1 
worms onto an NGM plate with food, and allowed to lay 
eggs for 3 h. At the L4 stage, worms were collected and 
washed with M9 buffer and placed on 9 cm NGM plates 
with 25 µM floxuridine (FUDR). On the third day of 
adulthood, worms were collected with M9 buffer and 
RNA was extracted. RNA was extracted by the phenol-
chloroform method using Trizol reagent (Thermo Fisher 
Scientific). A 0.4 mL slurry of glass beads in water was 
added to 1 mL Trizol. Synchronized adult day 3 worms 
were collected with 500 µL M9 buffer, and the worms 
were allowed to settle to the tip of the pipette tip. A drop 
of M9 buffer containing the majority of worms at the tip 
of the pipette was dropped into the Trizol solution. 
Worms were homogenized by 4 sets of vortexing using 
Micro Smash MS-100R (Tomy Seiko, Tokyo, Japan) at 
5,000 rpm for 2 min at 4° C. Additional vortexing cycles 
were carried out if worms were not completely 
homogenized. The solution was allowed to settle, and 800 
µL of the supernatant was transferred to a new tube. 200 
µL of Trizol and 200 µL of chloroform were added to the 
solution. The mixture was vortexed for 30 s and 
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centrifuged at 15,000 rpm for 15 min at 4° C. 600 µL of 
the supernatant was added to a tube containing 600 µL 2-
propanol. The solution was mixed by pipetting and 
incubated at room temperature for 10 min. This solution 
was centrifuged at 15,000 rpm for 15 min at 4° C. The 
supernatant was discarded, and 1 mL of 70% ethanol was 
added to the pellet. This solution was centrifuged at 
10,000 rpm for 5 min at 4° C. The supernatant  
was discarded and the pellet was air-dried. RNA was 
reconstituted in 30 µL ddH2O. RNA sequencing was 
performed on the HiSeq platform (Illumina). For 
bioinformatics analysis, reads were aligned using STAR 
[61], sorting and marking duplicates were done by Picard, 
and read counting was done by Featurecounts [62]. EdgeR 
[63] and R [58] were used to create figures to visualize 
differential gene expression. For differential expression, 
an FDR-adjusted q value < 0.05 was used. In a less 
stringent analysis of differentially expressed genes, an 
unadjusted p value < 0.05 was used.  
 
Quantitative PCR (qPCR) 
 
RNA was extracted from adult day-3 worms by the 
phenol-chloloroform method using Trizol reagent 
(Thermo Fisher Scientific) as described above. cDNA 
was synthesized using SuperScript III with oligo-dT 
primers (Thermo Fisher Scientific). 1 µL of oligo-dT 
primers, 1 µg of RNA, 1 µL of 10 mM dNTP mix and 
ddH20 was added to 13 µL. The solution was incubated 
at 65° C for 5 min and then on ice for 1 min. 4 µL of 5X 
First-Strand Buffer, 1 µL 0.1 M DTT, and 1 µL of 
SuperScript III was added to make 20 µL of solution. 
This solution was mixed by pipetting and incubated at 
50° C for 60 min. The reaction was inactivated by 
heating at 70° C for 15 min. qPCR was carried out using 
the cDNA with Luna Universal qPCR Master Mix (New 
England Biolabs, Ipswich, MA) using StepOnePlus 
(Thermo Fisher Scientific). 100 ng of template cDNA 
was used for Luna Universal qPCR. The peroxisomal 
membrane protein pmp-3 was used as the reference 
control for all qPCR experiments. Primers used for 




The Ahringer RNAi library was used to reduce the 
expression of target genes (F59H6.8, F59H6.9, B0047.3). 
Frozen stocks of the RNAi bacteria were streaked onto 
agar plates containing 100 µg/mL ampicillin. Single 
colonies of the RNAi bacteria were cultured for 8 h at  
37° C with vigorous shaking in lysogeny broth (LB) 
containing 100 µg/mL ampicillin. 100 µL of bacterial 
culture was spread on NGM plates with 50 µg/mL 
ampicillin and 1.0 mM isopropyl β-D-1-thio-
galactopyranoside (IPTG). Plates with RNAi bacteria 
were dried overnight with the lid on at room temperature 
(25° C). Adult wild-type worms were placed on RNAi 
plates and allowed to lay eggs for 3 h. The locomotor 
ability of the offspring was tested from the first day of 





All results are expressed as means with error bars 
representing a 95% confidence interval. For pairwise 
comparisons, Student’s two-tailed t test was used with 
Excel 2010 (Microsoft). For multiple comparisons to a 
control, one-way ANOVA was followed with Dunnett’s 
post hoc test using R [58]. For multiple comparisons, 
one-way ANOVA was followed with Tukey’s Honest 
Significant Difference test using R [58]. For lifespan 
comparisons, log-rank test was used with R [58]. 
Statistical significance was set at *P < 0.05; **P < 0.01; 




All isolated strains are available upon request. DNA and 
RNA sequencing results are available on NCBI 
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Supplementary Figure 1. dys-1(ix259) mutation does not cause progressive decline in locomotor ability. (A) Maximum velocities 
of 24 strains that show the exaggerated head bending phenotype after the fifth backcross on the second and fifth days of adulthood. N = 10–
15 worms per strain. (B) (Left) Travel distances of WT, OF1263 hda-3(ix241);dys-1(ix259) (4x BC), and OF1350 dys-1(ix259) (5x BC) worms. N = 
30–45 worms per strain for each day (10–15 worms from 3 biological replicate plates). (Right) Percent change in travel distance of WT, 
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Supplementary Figure 2. hda-3 mutation causes progressive decline in locomotor ability. (A) (Left) Travel distances of WT, 
OF1263 hda-3(ix241);dys-1(ix259) (4x BC), OF1353 hda-3(ix260);dys-1(ix259) and OF1354 hda-3(ix260);dys-1(ix259) worms on adult days 1, 3, 
and 5. (Right) Percent change in travel distance of WT, OF1263, OF1353, and OF1354 worms on adult day 5 compared to adult day 1. (B) 
(Left) Travel distances of WT, OF1355 hda-3(ix261), and OF1356 hda-3(ix261) worms on adult days 1, 3, and 5. (Right) Percent change in 
travel distance of WT, OF1355 hda-3(ix261), and OF1356 hda-3(ix261) worms on adult day 5 compared to adult day 1. (C) (Left) Travel 
distances of WT and hda-3(ok1991) worms on adult days 1, 3, and 5. (Right) Percent change in travel distance of WT and hda-3(ok1991) 
worms on adult day 5 compared to adult day 1. For travel distance measurements, N = 30–45 worms per strain for each day (10–15 worms 





Supplementary Figure 3. Evolutionary conservation of HDA-3 G271 residue. (A) Alignment of C. elegans (C. e.) HDA-3 to 
Saccharomyces cerevisiae HOS2, Drosophila melanogaster HDAC3, Danio rerio HDAC3, Mus Musculus HDAC3, and Homo sapiens HDAC3. 
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Supplementary Figure 4. Genes are downregulated in a narrow region on Chromosome IV. (A) Genomic location of strongly 




Supplementary Figure 5. Knockdown of BATH genes lead to progressive decline in travel distance. (A) Travel distances of worms 
fed with empty vector RNAi or RNAi targeted towards bath-1, bath-21, or bath-24. N = 30–45 worms per strain for each day (10–15 worms 
from 3 biological replicate plates). ***p < 0.001; **p < 0.01; *p < 0.05. 
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Supplementary Tables 
 
Supplementary Table 1. List of remaining mutations in backcrossed strains. 
Chrom. Pos. Ref. Alt. Gene Mutation type Effect* 
I 3258592 CA C Y54E10A.20 upstream gene variant modifier 
I 8160530 TTATA T T28B8.3 downstream gene variant modifier 
I 10731034 C T rpn-10 missense variant moderate 
I 10766899 C T daf-16 intron variant modifier 
I 10974485 C T Y52B11A.3 intron variant modifier 
I 11307424 C T H25P06.5 synonymous variant low 
I 11536456 C T dys-1 splice acceptor variant high 
I 11644705 C T W04G5.9 intron variant modifier 
I 11726250 C T F35E2.9 missense variant moderate 
I 11808061 G T T02G6.2-T02G6.4 intergenic region modifier 
I 11832340 C T Y47H9C.1 missense variant moderate 
I 11864150 T A ced-1 intron variant modifier 
I 11896398 C T Y47H9C.12 upstream gene variant modifier 
I 11914682 C T hda-3 missense variant moderate 
I 11927975 C T wve-1 upstream gene variant modifier 
I 12008815 C T fbxa-122 downstream gene variant modifier 
I 12176794 C T R05D7.3 intron variant modifier 
I 12298210 C T F56H6.7 missense variant moderate 
I 12341691 C T nhr-217 intron variant modifier 
I 12343381 T A T09E11.11 upstream gene variant modifier 
I 12414199 C T E03H4.5 intron variant modifier 
I 12493515 C T T27F6.6 synonymous variant low 
I 12970406 G A eif-6 downstream gene variant modifier 
I 14083393 A C gadr-6 upstream gene variant modifier 
III 2340737 A C Y54F10BM.1 intron variant modifier 
III 3385124 A AG hecw-1 upstream gene variant modifier 
III 3786851 T TTC acy-3 upstream gene variant modifier 
III 6301707 T TC F47D12.9 upstream gene variant modifier 
IV 1226960 T C W09G12.8 intron variant modifier 
IV 12319292 TG T F19B6.9 downstream gene variant modifier 
IV 12319295 T A F19B6.9 upstream gene variant modifier 
IV 13506453 GA G nlp-17 upstream gene variant modifier 




H08M01.74 downstream gene variant modifier 







T22H9.1 intron variant modifier 
V 1500601 G A sru-27 missense variant moderate 
V 13231585 T G C34D1.8 downstream gene variant modifier 
V 13697695 C T T01D3.1 missense variant moderate 









toca-1 intron variant modifier 
X 2008595 TA T Y40A1A.1-
Y102A11A.9 
intergenic region modifier 
X 3314891 A AT F11D5.12 upstream gene variant modifier 
X 4241974 A G W01H2.t1 upstream gene variant modifier 
X 4674025 G GT F16H11.1 downstream gene variant modifier 
X 6357781 C CCCAT C03B1.10 frameshift variant high 
X 8191585 G GT C17H11.6 intron variant modifier 
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X 11646516 A C T04F8.15 upstream gene variant modifier 
X 12502801 T TACGAAAAATAGA
TTGTTAC 
sdz-19 intron variant modifier 
Candidate causative mutation sites for the OF1262 strain.  
*Putative impact of mutation as categorized by snpEff: high (splice site variant, frameshift variant) > moderate (missense 
variant) > low (synonymous variant) > modifier (upstream gene variant (5’UTR), downstream gene variant (3’UTR), intron 
variant, intergenic variant). 
 
Supplementary Table 2. Average read counts and p values of downregulated region on Chromosome II. 
Gene Chr Start Strand 
Avg Read  
Count WT 
Avg Read  
Count OF1263 
Avg Read  
Count OF1350 
p value  
OF1263 vs. WT 
p value  
OF1263 vs. OF1350 
F59H6.3 II 2017450 + 544.3333333 503.75 617.5 0.850896676 0.560942062 
F59H6.2 II 2019654 + 46.33333333 37.25 57 0.945386699 0.48335894 
cya-2 II 2022673 - 647.6666667 145.75 342.25 0.000111143 0.017196088 
bath-21 II 2014902 - 500.3333333 85.75 492.5 0.00000122 0.00000011 
bath-1 II 2027612 - 1753 233 2190.75 2.69E-10 5.06E-14 
bath-3 II 2029236 - 548.6666667 248.5 902 0.044371025 0.000061 
bath-5 II 2030753 - 7225.666667 2460.75 8269.75 0.000945556 0.0000203 
btb-4 II 2032316 + 2886 456.5 1612 0.00000698 0.000828007 
F59H6.14 II 2033586 + 48.33333333 15 23.25 0.025843936 0.342383526 
F59H6.13 II 2034351 - 0 0 0 1 1 
bath-19 II 2035695 - 1246 730.25 1966.25 0.30014777 0.004494907 
bath-20 II 2040276 - 101 40.75 77.5 0.104265019 0.179052293 
btb-3 II 2043089 - 157.3333333 95.5 249.75 0.456879336 0.022200842 
bath-24 II 2044619 - 1507.333333 412.5 1697.5 0.0000992 0.0000024 
math-1 II 2046053 - 27.66666667 8.5 17 0.182230378 0.324120223 
bath-14 II 2048061 - 218 84.5 301.75 0.065982827 0.001813642 
F07E5.4 II 2050023 - 0 0 2 1 0.199767663 
fbxb-35 II 2051672 + 43.66666667 151.75 109.5 0.00256399 0.393136077 
F07E5.5 II 2053919 - 6974.666667 7446.25 9206.5 0.400658623 0.389501995 
 
Supplementary Table 3. INTERPRO analysis of protein domain enrichment in genes downregulated in OF1263 strain 
vs. OF1350 and WT. 
Category Term Count % PValue Genes 
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3 1.357466 0.006103 WBGENE00017594, 
WBGENE00003959, 
WBGENE00019682 







Supplementary Table 4. List of strains used in this study. 
Strain Genotype Obtained from 
OF1262 hda-3(ix241);dys-1(ix259) I Isolated in previous study (Kawamura and Maruyama, 
2019); 
Also referred to as ix241 
OF1263  hda-3(ix241);dys-1(ix259) I (4x backcrossed) Isolated in previous study (Kawamura and Maruyama, 
2019); 
Also referred to as ix241(4x BC) 
OF1350 dys-1(ix259) I (5x backcrossed) This study 
OF1353 hda-3(ix260);dys-1(ix259) I #1 This study. Independent CRISPR strain from OF1354 
(Same injection mixture). 
OF1354 hda-3(ix260);dys-1(ix259) I;  #2 This study. Independent CRISPR strain from OF1353 
(Same injection mixture). 
OF1355 hda-3(ix261) I (2x backcrossed) #1 This study. Independent CRISPR strain from OF1356 
(Same injection mixture). 
OF1356 hda-3(ix261) I (2x backcrossed) #2 This study. Independent CRISPR strain from OF1355 
(Same injection mixture). 
RB1618 hda-3(ok1991) I CGC 
CF1038 daf-16(mu86) I CGC 
PS3551 hsf-1(sy441) I CGC 
LS292 dys-1(cx18) I CGC 
BZ33 dys-1(eg33) I CGC 
List of strain, genotype, and source of C. elegans used in this study. 
 
Supplementary Table 5. List of primers used in this study. 
Primer name 5'-3' Sequence 
dys-1(ix259) 5' atgggcatgatgggtgtcaaatgaa 
dys-1(ix259) 3' cagaaaggcttccaccagtcggttg 
hda-3(ix241) 5' ggaatttgaaatttccggcaaatgtgcgaatggca 
hda-3(ix241) 3' tccacgaggagtacacgagagcttcttcgtaa 
bath-1 qpcr 5' ggttatcgatgatgatgacgtg 
bath-1 qpcr 3' gagacaagactttttcaaattgtcc 
bath-21 qpcr 5' ttctcagaaagttccttgcctc 
bath-21 qpcr 3' caaccgtgtcatcatctatagc 
bath-24 qpcr 5' tgcgattgatgattctaccatcg 
bath-24 qpcr 3' gagaggcaaacggttttcaaatt 
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pmp-3 qpcr 5’ tggccggatgatggtgtcgc 
pmp-3 qpcr 3’ acgaacaatgccaaaggccagc 
List of primers used for genotyping and qPCR. 
 
Supplementary Table 6. List of single-stranded oligodeoxynucleotide sequences used in this study. 
ssODN name 5'-3' sequence 








List of single-stranded oligodeoxynucleotide sequences used to repair the hda-3(ix241) allele  to WT and to re-introduce the 
hda-3(ix241) allele into the WT background. 
 
 
 
 
